Beijing Tong Ren Tang Chinese Medicine Company Limited (HKG:3613)
Hong Kong · Delayed Price · Currency is HKD 6.90
-0.02 (-0.29%)
Jul 31, 2026, 4:08 PM HKT
HKG:3613 Market Cap
HKG:3613 has a market cap or net worth of 5.78 billion as of July 31, 2026. Its market cap has decreased by -26.91% in one year.
Market Cap
5.78B
Enterprise Value
3.79B
Revenue
1.51B
Ranking
n/a
PE Ratio
14.54
Stock Price
6.90
ChartMarket Cap Chart
Since May 7, 2013, HKG:3613's market cap has increased from 5.22B to 5.78B, an increase of 10.57%. That is a compound annual growth rate of 0.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 5.78B | -18.44% |
| Dec 31, 2025 | 7.08B | -3.64% |
| Dec 31, 2024 | 7.35B | -27.68% |
| Dec 29, 2023 | 10.16B | 5.93% |
| Dec 30, 2022 | 9.59B | -14.61% |
| Dec 31, 2021 | 11.23B | 64.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CanSino Biologics | 9.75B |
| Shandong Xinhua Pharmaceutical Company | 9.08B |
| CF PharmTech | 8.16B |
| Sihuan Pharmaceutical Holdings Group | 8.12B |
| Luye Pharma Group | 8.11B |
| China Traditional Chinese Medicine Holdings Co. | 7.25B |
| SSY Group | 6.88B |
| Shanghai Fudan-Zhangjiang Bio-Pharmaceutical | 6.79B |